CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $96,431
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$96,431. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 97 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-12-01 | FUERST THOMAS RICHARD EVP, Chief Scientific Officer | Grant or award · Stock Options (right to buy) | +75,000 | 75,000 | ||
| 2011-12-01 | FUERST THOMAS RICHARD EVP, Chief Scientific Officer | Grant or award · Stock Options (right to buy) | +29,545 | 29,545 | ||
| 2011-11-22 | FUERST THOMAS RICHARD SVP, Chief Scientific Officer | Purchase | +5,000 | $1.27 | $6K | 15,000 |
| 2011-11-10 | FUERST THOMAS RICHARD EVP, Chief Scientific Officer | Purchase | +10,000 | $1.51 | $15K | 10,000 |
| 2010-12-08 | FUERST THOMAS RICHARD Chief Scientific Officer | Grant or award · Stock Options (right to buy) | +75,000 | 75,000 | ||
| 2010-05-06 | FUERST THOMAS RICHARD SVP, Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2010-04-05 | FUERST THOMAS RICHARD Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +350,000 | 350,000 |
Page 1 of 1 · 7 trades